BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals

Reuters

01/15

BRIEF-<a href="https://laohu8.com/S/MAYND">Mayne Pharma</a> Receives Notice Of Appeal By Cosette Pharmaceuticals

Jan 15 (Reuters) - Mayne Pharma Group Ltd MYX.AX:

RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEAL
CONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEAL
GROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERS

Further company coverage: MYX.AX

((Reuters.Briefs@thomsonreuters.com;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2603567824"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603567824\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603567824?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-15 13:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603567824","market":"us","top_or_hot":-1,"title":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/MAYND\">Mayne Pharma</a> Receives Notice Of Appeal By Cosette Pharmaceuticals</title></head><body><p><span>Jan 15 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MYXDA.AU\">Mayne Pharma Group Ltd</a> <span>MYX.AX</span>:</p><ul><li><p>RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEAL</p></li><li><p>CONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEAL</p></li><li><p>GROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERS</p></li></ul><p>Further company coverage: <span>MYX.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-15 13:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/MAYND\">Mayne Pharma</a> Receives Notice Of Appeal By Cosette Pharmaceuticals</title></head><body><p><span>Jan 15 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MYXDA.AU\">Mayne Pharma Group Ltd</a> <span>MYX.AX</span>:</p><ul><li><p>RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEAL</p></li><li><p>CONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEAL</p></li><li><p>GROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERS</p></li></ul><p>Further company coverage: <span>MYX.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MYX.AU","symbol_name":"MAYNE PHARMA GROUP LTD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:1","article_id":"2603567824","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603567824","pubTimestamp":1768453957,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette PharmaceuticalsJan 15  - Mayne Pharma Group Ltd MYX.AX:RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEALCONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEALGROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERSFurther company coverage: MYX.AX ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MYX.AU":"MAYNE PHARMA GROUP LTD","BK7508":"医药生物股","BK7096":"制药"},"translate_title":"简介-Mayne Pharma收到Cosette Pharmaceuticals的上诉通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MYX.AU":0.9},"content_text":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette PharmaceuticalsJan 15 (Reuters) - Mayne Pharma Group Ltd MYX.AX:RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEALCONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEALGROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERSFurther company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}